Switzerland has one of the lowest vaccination rates in Europe.
Keystone / Laurent Gillieron
Several Swiss cantons have objected to a government proposal to offer CHF50 ($54) vouchers to people who persuade others to take a Covid-19 vaccination.
The idea was presented last week as part of a package of measures to boost vaccination rates in the country. With under 60% of the population double jabbed, Switzerland has one of the lowest rates in Europe.
The government asked cantons to comment on its proposals, which also included a dedicated “vaccination week”, mobile vaccination units and an educational drive.
On Wednesday, as the consultation phase comes to a close, the Swiss news agency Keystone-SDA reports that some of the 26 cantons are against the voucher scheme.
These include Zurich, Appenzell Inner Rhodes, Lucerne, Obwalden, Schwyz, Aargau, Glarus, St Gallen, Fribourg, Vaud and Thurgau. Negative comments include the complaint that such a scheme would be “un-Swiss” or that it could discriminate against people who choose not to get vaccinated.
Only Basel City has publicly come out in favour of the vouchers, says Keystone-SDA. The thoughts of other cantons are not yet known.
Earlier this week, Swiss public broadcaster SRF and the Neue Zürcher Zeitung newspaper ran reports of lawyers questioning the legality of the voucher scheme.
The government is due to announce its final decision on October 13 after it has digested the consultation feedback.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Government resists pressure to extend free Covid testing
This content was published on
The government is sticking to its decision to end free Covid testing as of October 11. The money saved will go into a new vaccination push.
All you need to know about the Swiss Covid certificate
This content was published on
Many public places in Switzerland now require a Covid certificate. Here is what you need to know if you are travelling here.
Many Swiss could prefer wider vaccine choice, survey finds
This content was published on
The representative survey by research group Sotomo, reported in the SonntagsZeitung, was carried out in July, well before the introduction of the Covid certificate obligation this week. However, according to experts interviewed by the paper, it could be a sign that Switzerland’s vaccination campaign would be boosted by making available other jabs which don’t use…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.